$8.59
-0.50-5.50%
At close: -
$8.59
0.000.00%
After Hours: Feb 21, 4:01 PM EDT
INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of INmune Bio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-31 | $-0.60 | $-0.50 | -20.0 % |
Q2 | 2024-08-01 | $-0.50 | $-0.63 | 20.6 % |
Q1 | 2024-05-09 | $-0.61 | $-0.53 | -15.1 % |
Q4 | 2024-03-28 | $-0.47 | $-0.44 | -6.82 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2024-05-09 | $14.00K | $30.00K | -53.3 % |
Q4 | 2024-03-28 | $28.00K | $40.00K | -30.0 % |
Q3 | 2021-11-03 | $14.00K | $970.00K | -98.6 % |
INmune Bio (INMB) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
The Actual EPS was $-0.60, which missed the estimate of $-0.50.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.